Yoshiyama Annie
SEC CIK 1835208 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | SVP, Fin | 124.5K | — | $42.8K | 4 | 2025-01-24 | 2026-04-21 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 16:16 | 2026-04-21 | ALLO | Allogene Therapeutics, Inc. | Yoshiyama Annie | SVP, Fin | S - Sale | $2.31 | -9,586 | 124.5K | -7% | -$22.1K | |
| D | 2026-02-04 | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Yoshiyama Annie | SVP, Fin | S - Sale | $1.72 | -4,167 | 130.3K | -3% | -$7,167 |
| 2025-04-23 | 2025-04-21 | ALLO | Allogene Therapeutics, Inc. | Yoshiyama Annie | SVP, Fin | S - Sale | $1.41 | -9,601 | 130.7K | -7% | -$13.5K | |
| D | 2025-01-28 | 2025-01-24 | ALLO | Allogene Therapeutics, Inc. | Yoshiyama Annie | SVP, Fin | A - Grant | $0.00 | +36.2K | 138.0K | +36% | $0 |
Purchase Sale Sale after option exercise All abbreviations